Cantor Fitzgerald Comments on AXSM FY2025 Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Axsome Therapeutics in a note issued to investors on Tuesday, February 11th. Cantor Fitzgerald analyst C. Duncan expects that the company will earn ($2.88) per share for the year. Cantor Fitzgerald has a “Overweight” […]
